Direct oral anticoagulants were associated with lower risks of ischemic stroke or systemic embolism and bleeding compared with warfarin. The study included patients with atrial fibrillation (AF) and ...

Boston Scientific (BSX) announced an update on their ongoing clinical study.Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools ...

At both 6 months and 12 months follow-up, the rivaroxaban group was found to have more of these events than the apixaban group. Credit: Getty Images. In patients with atrial fibrillation and valvular ...

The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their 1,000th WATCHMAN device procedure, a minimally invasive solution for ...

No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in ...

SAN FRANCISCO -- Surprisingly, a course of direct oral anticoagulation (DOAC) may be the safer choice for antithrombotic treatment after left atrial appendage (LAA) occlusion, according to the ANDES ...

Baptist Heart & Vascular Institute cardiologists, advanced practice providers and BHVI leadership recently gathered to celebrate the performance of its 1,000th Watchman procedure. The procedure is a ...

When David Reed was first diagnosed with atrial fibrillation (AFib), the treatment felt more unsettling than the disease. The most common form of heart arrhythmia, AFib prompts the heart’s upper ...

Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for severe mitral regurgitation are more than twice as likely to die or be ...

If you don’t know someone who has experienced Atrial Fibrillation, commonly referred to as AFib, odds are you will at some point. Estimates show up to 12 million people may be affected by AFib by the ...

Johnson & Johnson MedTech has strengthened its cardiac treatment offerings with the $400 million acquisition of Laminar Inc., a private medical device company headquartered in Santa Rosa, Calif. The ...